ArticleAmerican journal of cancer research2023

lncRNA ASBEL and lncRNA Erbb4-IR reduce chemoresistance against gemcitabine and cisplatin in stage IV lung squamous cell carcinoma via the microRNA-21/LZTFL1 axis.

Zong-Ying Liang et al.PubMed ↗Full text ↗

No numbers read from the abstract.